Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 23 May 2013 | By Alexander Gaffney, RAC,
EU regulators with the European Medicines Agency (EMA) have announced the issuance of six recommendations stemming from a workshop they recently conducted regarding methods to reduce medication errors.
That workshop, held in February 2013, brought together regulators across the EU in the hopes of raising awareness around new legal requirements for reporting medication errors and to generate best practices for EU regional regulators.
Those errors, as defined by the agency, include "unintended errors in the prescribing, dispensing or administration of a medicine while in the control of a healthcare professional, patient or consumer."
"They are the single most common preventable cause of adverse events in medication practice," EMA added.
The outcome of that workshop is a report issued by the agency that calls for six recommended actions to be implemented by regulators:
EMA said it is now working with regional regulators and the European Commission to prioritize these recommendations and seek paths toward implementation.
Tags: Medication Errors, Report, Latest News, workshop, EU